Pharmacist Biosimilars | Specialty Pharmacy | Treatment Guidelines Podcast 45 credit minutes

With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions.

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Explain the role of biosimilars in the treatment of inflammatory conditions.
2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies.

Faculty

Rachel Maynard, PharmD

GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Reemal Zaheer, PharmD, CSP

Pharmacist
Johns Hopkins Medicine

Disclosures:

Reemal Zaheer has no relevant financial relationships with ineligible companies to disclose.

Course Details